The SELECT trial is the only large-scale cardiovascular outcomes trial completed for either drug in an obesity population
At ManUp and WomanUp, we utilize this synthetic peptide fragment derived from human growth hormone to help patients achieve significant fat loss while preserving lean muscle mass, making it an ideal component of comprehensive body transformation programs
Appetite, digestion speed, and blood sugar regulation return to baseline, often causing hunger and cravings to reappear
This reduces the integrity of the fat cells, without destroying them, allowing for a gradual, non-aggressive reduction in fat volume
Challenges and Limitations in Research While the early results are promising, it's important to acknowledge the challenges and limitations in this field of research
Hypoglycaemia, though uncommon with Ozempic monotherapy, becomes more likely when combined with insulin or sulfonylureas